These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Advantages of preventing Rh isoimmunization]. Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466 [TBL] [Abstract][Full Text] [Related]
7. [Prevention of maternal isoimmunization to RhD antigen]. Baptista González HA; Rosenfeld Mann F Salud Publica Mex; 2004; 46(3):194-5; author reply 196-7. PubMed ID: 15368858 [No Abstract] [Full Text] [Related]
8. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients. Ben-David G; Sheiner E; Levy A; Erez O; Mazor M J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822 [TBL] [Abstract][Full Text] [Related]
9. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security. Zavala C; Salamanca F Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398 [TBL] [Abstract][Full Text] [Related]
10. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin. Hermann M; Kjellman H; Ljunggren C Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582 [TBL] [Abstract][Full Text] [Related]
11. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy. Okwundu CI; Afolabi BB Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818 [TBL] [Abstract][Full Text] [Related]
12. [Transvaginal bleeding in pregnancy, as risk factor of Rhesus-D antigen isoimmunization]. Hernández-Andrade E; Ahued-Ahued JR Salud Publica Mex; 2003; 45(6):492-6. PubMed ID: 14974293 [TBL] [Abstract][Full Text] [Related]
13. Costs and benefits of non-invasive fetal RhD determination. Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024 [TBL] [Abstract][Full Text] [Related]
14. Dose of anti-D immunoglobulin for the prevention of RhD immunisation after RhD-incompatible platelet transfusions. Murphy MF; Lee D Vox Sang; 1993; 65(1):73-4. PubMed ID: 8362520 [No Abstract] [Full Text] [Related]
15. Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis. Neovius M; Tiblad E; Westgren M; Kublickas M; Neovius K; Wikman A BJOG; 2016 Jul; 123(8):1337-46. PubMed ID: 26663771 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women. Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I; BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of anti-D allo-immunization during pregnancy]. Branger B; Winer N J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833 [TBL] [Abstract][Full Text] [Related]
18. Prevention of RhD alloimmunization in RhD negative women. Lubusky M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704 [TBL] [Abstract][Full Text] [Related]
19. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland. Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198 [TBL] [Abstract][Full Text] [Related]
20. [Guideline for prevention of RhD alloimmunizationin RhD negative women]. Lubušký M; Procházka M; Simetka O; Holusková I Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]